Ligand Pharmaceuticals Incorporated

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/14/02 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 4
02/13/02 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
8
02/11/02 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
11/07/01 10-Q Quarterly report pursuant to Section 13 or 15(d) 24
08/02/01 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
67
07/30/01 S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
48
05/07/01 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
78
04/20/01 DEF 14A Definitive proxy statements 67
03/29/01 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
165
03/07/01 15-12G Notice of termination of registration of a class of securities under Section 12(g) 1
RSS